Dear Colleagues,

It’s a privilege to invite you to the 9th Aegean Hematology Oncology Symposium which will be held on 15-18 September 2022 in Chios, Greece. This is our first live meeting after COVID-19 pandemic, and I would like to welcome you again to the beautiful island of Chios. The Symposium is categorized and organized as International Congress under the auspices of the Balkan Myeloma Study Group. It is co-organized by the National and Kapodistrian University of Athens (School of Medicine) in collaboration with the Turkish Medical Association of EHOD (Aegean Hematology Oncology Society). For one more year it is a privilege and a great honor for AHOS to be organized under the auspices of the European Hematology Association, “Scientific Working Group MM”.

This meeting is planned to share country perspectives on Hematology Oncology topics between Greek and Turkish Clinicians, to exchange experiences and to create the basis for multi-center, multi- national studies. During the last years, there was a significant progress in the biology of hematological malignancies that led to the development of several novel drugs in the field. Furthermore, COVID-19 has made several changes in the management of hematology patients, while several complications affecting the blood are developed during COVID-19 or post-COVID-19. The scientific program includes all these data presented by experienced hematologists and it is organized in well-balanced interactive sessions and teaching programs focusing on the needs of Hematology/Oncology Clinicians. This year oral and poster sessions are included again in the program to facilitate the scientific dialogue between Greek and Turkish colleagues and enhance the collaboration between the hematologists of both countries.

We hope that you enjoy the scientific program and we thank you in advance for your contribution in the development of this meeting in order to be even better than the previous AHOS.

On behalf of the Organizing Committee

Evangelos Terpos
Chair of the Symposium